arrow
J

Junichi Sakamoto

japanese foundation for multidisciplinary treatment of cancer
H指数:45
被引数:7,000

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study

乳腺癌患者中,伴有1至3个阳性微转移或巨转移的哨兵淋巴结的腋窝手术:一项观察性研究

2025-05-250
OAAI
Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy

二周疗法伊立替康联合顺铂与单用伊立替康在晚期胃癌二线治疗中的疗效差异(无论是否接受过胃切除术)

2024-11-250
PRE
Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA
2022-07-054
PRE
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
2022-06-284
OAAI
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)
2022-02-159
OAAI
Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials

通过对来自大型随机对照试验的个体患者数据的汇总分析,对D2解剖后胃癌辅助化疗的临床生物标志物

2021-08-075
OA
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
2021-05-062
OAAI